Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 5436745, 11 pages
http://dx.doi.org/10.1155/2016/5436745
Research Article

Rutin Attenuates Hepatotoxicity in High-Cholesterol-Diet-Fed Rats

1Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia
2Department of Biomedical Dental Sciences, College of Dentistry, University of Dammam, Dammam 31441, Saudi Arabia

Received 7 December 2015; Revised 29 February 2016; Accepted 10 March 2016

Academic Editor: Reiko Matsui

Copyright © 2016 Shakir D. AlSharari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Clark, “The epidemiology of nonalcoholic fatty liver disease in adults,” Journal of Clinical Gastroenterology, vol. 40, no. 1, pp. S5–S10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. J. P. Ong and Z. M. Younossi, “Epidemiology and natural history of NAFLD and NASH,” Clinics in Liver Disease, vol. 11, no. 1, pp. 1–16, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Lazo and J. M. Clark, “The epidemiology of nonalcoholic fatty liver disease: a global perspective,” Seminars in Liver Disease, vol. 28, no. 4, pp. 339–350, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J.-G. Fan and G. C. Farrell, “Epidemiology of non-alcoholic fatty liver disease in China,” Journal of Hepatology, vol. 50, no. 1, pp. 204–210, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. St George, A. Bauman, A. Johnston, G. Farrell, T. Chey, and J. George, “Independent effects of physical activity in patients with nonalcoholic fatty liver disease,” Hepatology, vol. 50, no. 1, pp. 68–76, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Gan, S. Chitturi, and G. C. Farrell, “Mechanisms and implications of age-related changes in the liver: nonalcoholic fatty liver disease in the elderly,” Current Gerontology and Geriatrics Research, vol. 2011, Article ID 831536, 12 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Manchanayake, S. Chitturi, C. Nolan, and G. C. Farrell, “Postprandial hyperinsulinemia is universal in non-diabetic patients with nonalcoholic fatty liver disease,” Journal of Gastroenterology and Hepatology, vol. 26, no. 3, pp. 510–516, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. J.-G. Fan, “Epidemiology of alcoholic and nonalcoholic fatty liver disease in China,” Journal of Gastroenterology and Hepatology, vol. 28, supplement 1, pp. 11–17, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. G. C. Farrell and C. Z. Larter, “Nonalcoholic fatty liver disease: from steatosis to cirrhosis,” Hepatology, vol. 43, no. 2, supplement 1, pp. S99–S112, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. S. S. Al-Rejaie, A. M. Aleisa, M. M. Sayed-Ahmed et al., “Protective effect of rutin on the antioxidant genes expression in hypercholestrolemic male Westar rat,” BMC Complementary and Alternative Medicine, vol. 13, article no. 136, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Wang, J. Sun, Y. Ma, G. Wu, Y. Shi, and G. Le, “Increased oxidative stress and the apoptosis of regulatory T cells in obese mice but not resistant mice in response to a high-fat diet,” Cellular Immunology, vol. 288, no. 1-2, pp. 39–46, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. A. E. Feldstein, A. Canbay, P. Angulo et al., “Hepatocyte apoptosis and Fas expression are prominent features of human nonalcoholic steatohepatitis,” Gastroenterology, vol. 125, no. 2, pp. 437–443, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. P. S. Ribeiro, H. Cortez-Pinto, S. Solá et al., “Hepatocyte apoptosis, expression of death receptors, and activation of NF-κB in the liver of nonalcoholic and alcoholic steatohepatitis patients,” American Journal of Gastroenterology, vol. 99, no. 9, pp. 1708–1717, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. A. E. Feldstein and G. J. Gores, “Apoptosis in alcoholic and nonalcoholic steatohepatitis,” Frontiers in Bioscience, vol. 10, no. 3, pp. 3093–3099, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. M. E. Guicciardi and G. J. Gores, “Apoptosis: a mechanism of acute and chronic liver injury,” Gut, vol. 54, no. 7, pp. 1024–1033, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Kayadibi, E. Sertoglu, and M. Uyanik, “Which diagnostic tool for the prediction of intermediate liver fibrosis stages?” European Journal of Gastroenterology and Hepatology, vol. 27, no. 2, p. 182, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. C. F. Subasi, U. E. Aykut, and Y. Yilmaz, “Comparison of noninvasive scores for the detection of advanced fibrosis in patients with nonalcoholic fatty liver disease,” European Journal of Gastroenterology and Hepatology, vol. 27, no. 2, pp. 137–141, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Canbay, S. Friedman, and G. J. Gores, “Apoptosis: the nexus of liver injury and fibrosis,” Hepatology, vol. 39, no. 2, pp. 273–278, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Takehara, T. Tatsumi, T. Suzuki et al., “Hepatocyte-specific disruption of Bcl-x L leads to continuous hepatocyte apoptosis and liver fibrotic responses,” Gastroenterology, vol. 127, no. 4, pp. 1189–1197, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Canbay, P. Taimr, N. Torok, H. Higuchi, S. Friedman, and G. J. Gores, “Apoptotic body engulfment by a human stellate cell line is profibrogenic,” Laboratory Investigation, vol. 83, no. 5, pp. 655–663, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Watanabe, A. Hashmi, D. A. Gomes et al., “Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via toll-like receptor 9,” Hepatology, vol. 46, no. 5, pp. 1509–1518, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Shi and J. Massagué, “Mechanisms of TGF-β signaling from cell membrane to the nucleus,” Cell, vol. 113, no. 6, pp. 685–700, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Euler-Taimor and J. Heger, “The complex pattern of SMAD signaling in the cardiovascular system,” Cardiovascular Research, vol. 69, no. 1, pp. 15–25, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Schneiders, J. Heger, P. Best, H. M. Piper, and G. Taimor, “SMAD proteins are involved in apoptosis induction in ventricular cardiomyocytes,” Cardiovascular Research, vol. 67, no. 1, pp. 87–96, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Wang, J. Hao, S. C. Jones, M.-S. Yee, J. C. Roth, and I. M. C. Dixon, “Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 282, no. 5, pp. H1685–H1696, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. W. Huang, L. Li, X. Tian et al., “Astragalus and Paeoniae radix rubra extract inhibits liver fibrosis by modulating the transforming growth factorβ/Smad pathway in rats,” Molecular Medicine Reports, vol. 11, no. 2, pp. 805–814, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Herbst, T. Wege, S. Milani et al., “Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis,” The American Journal of Pathology, vol. 150, no. 5, pp. 1647–1659, 1997. View at Google Scholar · View at Scopus
  28. N. Nieto, J. A. Dominguez-Rosales, L. Fontana et al., “Rat hepatic stellate cells contribute to the acute-phase response with increased expression of α1 (I) and α1 (IV) collagens, tissue inhibitor of metalloproteinase-1, and matrix-metalloproteinase-2 messenger RNAs,” Hepatology, vol. 33, no. 3, pp. 597–607, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Kurita, K. Takeuchi, Y. Hayashi et al., “Significance of serum Zn-α2-glycoprotein for the regulation of blood pressure,” Hypertension Research, vol. 38, no. 4, pp. 244–251, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Dooley, J. Hamzavi, L. Ciuclan et al., “Hepatocyte-specific Smad7 expression attenuates TGF-β-mediated fibrogenesis and protects against liver damage,” Gastroenterology, vol. 135, no. 2, pp. 642–659, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Sass, R. Barikbin, and G. Tiegs, “The multiple functions of heme oxygenase-1 in the liver,” Zeitschrift für Gastroenterologie, vol. 50, no. 1, pp. 34–40, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. Y.-C. Yang, C.-K. Lii, A.-H. Lin et al., “Induction of glutathione synthesis and heme oxygenase 1 by the flavonoids butein and phloretin is mediated through the ERK/Nrf2 pathway and protects against oxidative stress,” Free Radical Biology and Medicine, vol. 51, no. 11, pp. 2073–2081, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. H. Choi, “The cytoprotective effect of isorhamnetin against oxidative stress is mediated by the upregulation of the Nrf2-dependent HO-1 expression in C2C12 myoblasts through scavenging reactive oxygen species and ERK inactivation,” General Physiology and Biophysics, 2016. View at Publisher · View at Google Scholar
  34. Y. H. Choi, “The cytoprotective effects of ethanol extract of Ecklonia cava against oxidative stress are associated with upregulation of Nrf2-mediated HO-1 and NQO-1 expression through activation of the MAPK pathway,” General Physiology and Biophysics, vol. 35, no. 1, pp. 45–53, 2016. View at Publisher · View at Google Scholar
  35. R. Acquaviva, R. Lanteri, G. Li Destri et al., “Beneficial effects of rutin and L-arginine coadministration in a rat model of liver ischemia-reperfusion injury,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 296, no. 3, pp. G664–G670, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. Q. Lin, S. Weis, G. Yang et al., “Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress,” The Journal of Biological Chemistry, vol. 282, no. 28, pp. 20621–20633, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Lawrence, “The nuclear factor NF-kappaB pathway in inflammation,” Cold Spring Harbor Perspectives in Biology, vol. 1, no. 6, Article ID a001651, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. J. T. Rodgers, C. Lerin, W. Haas, S. P. Gygi, B. M. Spiegelman, and P. Puigserver, “Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1,” Nature, vol. 434, no. 7029, pp. 113–118, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Bergeron, J. M. Ren, K. S. Cadman et al., “Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis,” American Journal of Physiology-Endocrinology and Metabolism, vol. 281, no. 6, pp. E1340–E1346, 2001. View at Google Scholar · View at Scopus
  40. S. Seo, M.-S. Lee, E. Chang et al., “Rutin increases muscle mitochondrial biogenesis with AMPK activation in high-fat diet-induced obese rats,” Nutrients, vol. 7, no. 9, pp. 8152–8169, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. J. D. Potter, “Cancer prevention: epidemiology and experiment,” Cancer Letters, vol. 114, no. 1-2, pp. 7–9, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. P. N. Aleksandrov, T. V. Speranskaia, G. Bobkov Iu, V. A. Zagorevskii, and D. A. Zykov, “Effect of rutin and esculamine on models of aseptic inflammation,” Farmakologiia i Toksikologiia, vol. 49, no. 1, pp. 84–86, 1986. View at Google Scholar
  43. E. E. Deschner, J. Ruperto, G. Wong, and H. L. Newmark, “Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia,” Carcinogenesis, vol. 12, no. 7, pp. 1193–1196, 1991. View at Publisher · View at Google Scholar · View at Scopus
  44. A. López-Revuelta, J. I. Sánchez-Gallego, A. Hernández-Hernández, J. Sánchez-Yagüe, and M. Llanillo, “Membrane cholesterol contents influence the protective effects of quercetin and rutin in erythrocytes damaged by oxidative stress,” Chemico-Biological Interactions, vol. 161, no. 1, pp. 79–91, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. S. M. Artham, C. J. Lavie, R. V. Milani, and H. O. Ventura, “The obesity paradox: impact of obesity on the prevalence and prognosis of cardiovascular diseases,” Postgraduate Medicine, vol. 120, no. 2, pp. 34–41, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Bellentani, G. Saccoccio, F. Masutti et al., “Prevalence of and risk factors for hepatic steatosis in northern Italy,” Annals of Internal Medicine, vol. 132, no. 2, pp. 112–117, 2000. View at Google Scholar · View at Scopus
  47. P. Vitaglione, F. Morisco, G. Mazzone et al., “Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins,” Hepatology, vol. 52, no. 5, pp. 1652–1661, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. S. K. Das, V. Balakrishnan, S. Mukherjee, and D. M. Vasudevan, “Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 68, no. 4, pp. 323–334, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. H.-Y. Song, Z.-M. Mao, L.-L. Yang et al., “Dangfei liganning capsules attenuate the susceptibility of rat nonalcoholic fatty liver to carbon tetrachloride toxicity,” Journal of Traditional Chinese Medicine, vol. 31, no. 4, pp. 327–333, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. N. Kamalakkannan and P. S. M. Prince, “Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocin-induced diabetic wistar rats,” Basic and Clinical Pharmacology and Toxicology, vol. 98, no. 1, pp. 97–103, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Halcox and A. Misra, “Type 2 diabetes mellitus, metabolic syndrome, and mixed dyslipidemia: how similar, how different, and how to treat?” Metabolic Syndrome and Related Disorders, vol. 13, no. 1, pp. 1–21, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. Y.-W. Fu and H.-B. He, “Apoptosis of periodontium cells in streptozototocin- and ligature-induced experimental diabetic periodontitis in rats,” Acta Odontologica Scandinavica, vol. 71, no. 5, pp. 1206–1215, 2013. View at Publisher · View at Google Scholar · View at Scopus
  53. K. N. Otwombe, F. Laher, T. Tutu-Gxashe, G. Gray, and L. Mohapi, “The effect of a maturing antiretroviral program on early mortality for patients with advanced immune-suppression in Soweto, South Africa,” PLoS ONE, vol. 8, no. 11, Article ID e81538, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Dasgupta, J. Zheng, N. I. Perrone-Bizzozero, and O. A. Bizzozero, “Increased carbonylation, protein aggregation and apoptosis in the spinal cord of mice with experimental autoimmune encephalomyelitis,” ASN neuro, vol. 5, no. 1, Article ID e00111, 2013. View at Google Scholar · View at Scopus
  55. S. Arumugam, S. Mito, R. A. Thandavarayan et al., “Mulberry leaf diet protects against progression of experimental autoimmune myocarditis to dilated cardiomyopathy via modulation of oxidative stress and MAPK-mediated apoptosis,” Cardiovascular Therapeutics, vol. 31, no. 6, pp. 352–362, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. F. Bayatli, D. Akkuş, E. Kilic, R. Saraymen, and M. F. Sönmez, “The protective effects of grape seed extract on MDA, AOPP, apoptosis and eNOS expression in testicular torsion: an experimental study,” World Journal of Urology, vol. 31, no. 3, pp. 615–622, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. D. A. Papanicolaou, R. L. Wilder, S. C. Manolagas, and G. P. Chrousos, “The pathophysiologic roles of interleukin-6 in human disease,” Annals of Internal Medicine, vol. 128, no. 2, pp. 127–137, 1998. View at Publisher · View at Google Scholar · View at Scopus
  58. A. J. Thompson, A. J. Muir, M. S. Sulkowski et al., “Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 Hepatitis C virus,” Gastroenterology, vol. 139, no. 1, pp. 120–129.e18, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. R. Valentino, V. D'Esposito, F. Passaretti et al., “Bisphenol-A impairs insulin action and up-regulates inflammatory pathways in human subcutaneous adipocytes and 3T3-L1 cells,” PLoS ONE, vol. 8, no. 12, Article ID e82099, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. X. B. Cui, Y. Z. Chen, and F. Li, “Recent advances on relationship between phospholipase C epsilon-1 gene and tumor,” Zhonghua Bing Li Xue Za Zhi, vol. 41, no. 3, pp. 213–216, 2012. View at Google Scholar
  61. S. K. Das and V. Balakrishnan, “Role of cytokines in the pathogenesis of non-alcoholic fatty liver disease,” Indian Journal of Clinical Biochemistry, vol. 26, no. 2, pp. 202–209, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. M.-D. Jiang, H.-D. Ma, X.-F. Zhong, F.-W. Xie, and W.-Z. Zeng, “Effects of Erk signal transduction on the cell cycle of rat hepatic stellate cells stimulated by acetaldehyde,” Zhonghua Gan Zang Bing Za Zhi, vol. 11, no. 11, pp. 650–653, 2003. View at Google Scholar · View at Scopus
  63. B. Saile, C. Eisenbach, H. El-Armouche, K. Neubauer, and G. Ramadori, “Antiapoptotic effect of interferon-α on hepatic stellate cells (HSC): a novel pathway of IFN-α signal transduction via Janus kinase 2 (JAK 2) and caspase-8,” European Journal of Cell Biology, vol. 82, no. 1, pp. 31–41, 2003. View at Publisher · View at Google Scholar · View at Scopus
  64. M. A. Ganaie, T. H. Khan, N. A. Siddiqui, and M. N. Ansari, “Ameliorative effect of methanol extract of Rumex vesicarius on CCl4-induced liver damage in Wistar albino rats,” Pharmaceutical Biology, vol. 53, no. 8, pp. 1163–1167, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Peters, K.-H. Meyer zum Büschenfelde, and S. Rose-John, “The function of the soluble IL-6 receptor in vivo,” Immunology Letters, vol. 54, no. 2-3, pp. 177–184, 1996. View at Publisher · View at Google Scholar · View at Scopus
  66. D. Novick, H. Engelmann, D. Wallach, and M. Rubinstein, “Soluble cytokine receptors are present in normal human urine,” Journal of Experimental Medicine, vol. 170, no. 4, pp. 1409–1414, 1989. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Honda, S. Yamamoto, M. Cheng et al., “Human soluble IL-6 receptor: its detection and enhanced release by HIV infection,” Journal of Immunology, vol. 148, no. 7, pp. 2175–2180, 1992. View at Google Scholar · View at Scopus
  68. S. S. Edranov and P. A. Motavkin, “Apoptosis as a mechanism of maxillary sinus mucosa injury in rats after experimental transection of the maxillary nerve,” Bulletin of Experimental Biology and Medicine, vol. 153, no. 4, pp. 526–529, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. T. Kauss, D. Moynet, J. Rambert et al., “Rutoside decreases human macrophage-derived inflammatory mediators and improves clinical signs in adjuvant-induced arthritis,” Arthritis Research and Therapy, vol. 10, no. 1, article R19, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. M. Eder, G. Geissler, and A. Ganser, “IL-3 in the clinic,” Stem Cells, vol. 15, no. 5, pp. 327–333, 1997. View at Publisher · View at Google Scholar · View at Scopus
  71. D. E. Johnson, “Regulation of survival pathways by IL-3 and induction of apoptosis following IL-3 withdrawal,” Frontiers in Bioscience, vol. 3, pp. d313–d324, 1998. View at Google Scholar · View at Scopus
  72. H. Bessler, M. Bergman, and H. Salman, “Interleukin-3 and stress,” Biomedicine and Pharmacotherapy, vol. 54, no. 6, pp. 299–304, 2000. View at Publisher · View at Google Scholar · View at Scopus
  73. X.-G. Zhang, P. Xu, Q. Liu et al., “Effect of tea polyphenol on cytokine gene expression in rats with alcoholic liver disease,” Hepatobiliary and Pancreatic Diseases International, vol. 5, no. 2, pp. 268–272, 2006. View at Google Scholar · View at Scopus
  74. Y. Sheng, Y. Ma, Z. Deng, Z. Wang, and L. Ji, “Cytokines as potential biomarkers of liver toxicity induced by Dioscorea bulbifera L,” Bioscience Trends, vol. 8, no. 1, pp. 32–37, 2014. View at Publisher · View at Google Scholar · View at Scopus
  75. R.-M. Liu and K. A. Gaston Pravia, “Oxidative stress and glutathione in TGF-β-mediated fibrogenesis,” Free Radical Biology and Medicine, vol. 48, no. 1, pp. 1–15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. J. Schmutzhard, R. Glueckert, C. Pritz et al., “Sepsis otopathy: experimental sepsis leads to significant hearing impairment due to apoptosis and glutamate excitotoxicity in murine cochlea,” Disease Models & Mechanisms, vol. 6, no. 3, pp. 745–754, 2013. View at Publisher · View at Google Scholar · View at Scopus
  77. J. Zhao, M. Zhang, and Y. Chen, “Experimental research on the mechanisms of human multiple myeloma LP-1 cell apoptosis induced by oridonin,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 32, no. 12, pp. 1642–1646, 2012. View at Google Scholar · View at Scopus
  78. S. Öksüz, E. Ülkür, O. Öncül, G. T. Köse, Z. Küçükodac, and M. Urhan, “The effect of subcutaneous mesenchymal stem cell injection on statis zone and apoptosis in an experimental burn model,” Plastic and Reconstructive Surgery, vol. 131, no. 3, pp. 463–471, 2013. View at Publisher · View at Google Scholar
  79. S. Velayuthaprabhu, H. Matsubayashi, T. Sugi et al., “Expression of apoptosis in placenta of experimental antiphospholipid syndrome mouse,” American Journal of Reproductive Immunology, vol. 69, no. 5, pp. 486–494, 2013. View at Publisher · View at Google Scholar · View at Scopus
  80. A. Panasiuk, J. Dzieciol, B. Panasiuk, and D. Prokopowicz, “Expression of p53, Bax and Bcl-2 proteins in hepatocytes in non-alcoholic fatty liver disease,” World Journal of Gastroenterology, vol. 12, no. 38, pp. 6198–6202, 2006. View at Google Scholar · View at Scopus
  81. C. S. Lieber, M. A. Leo, X. Wang, and L. M. DeCarli, “Alcohol alters hepatic FoxO1, p53, and mitochondrial SIRT5 deacetylation function,” Biochemical and Biophysical Research Communications, vol. 373, no. 2, pp. 246–252, 2008. View at Publisher · View at Google Scholar · View at Scopus
  82. N. Edebali, İ. Ö. Tekin, B. Açıkgöz et al., “Apoptosis and necrosis in the circumventricular organs after experimental subarachnoid hemorrhage as detected with annexin V and caspase 3 immunostaining,” Neurological Research, vol. 36, no. 12, pp. 1114–1120, 2014. View at Publisher · View at Google Scholar · View at Scopus
  83. J. Lee, A. Padhye, A. Sharma et al., “A pathway involving farnesoid X receptor and small heterodimer partner positively regulates hepatic sirtuin 1 levels via MicroRNA-34a inhibition,” Journal of Biological Chemistry, vol. 285, no. 17, pp. 12604–12611, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. H. Hermeking, “p53 enters the MicroRNA world,” Cancer Cell, vol. 12, no. 5, pp. 414–418, 2007. View at Publisher · View at Google Scholar · View at Scopus
  85. T. Kodama, T. Takehara, H. Hikita et al., “Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice,” Journal of Clinical Investigation, vol. 121, no. 8, pp. 3343–3356, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. J. Vávrová and M. Řezáčová, “Importance of proapoptotic protein PUMA in cell radioresistance,” Folia Biologica, vol. 60, no. 2, pp. 53–56, 2014. View at Google Scholar · View at Scopus
  87. A. L. Gartel and A. L. Tyner, “The role of the cyclin-dependent kinase inhibitor p21 in apoptosis,” Molecular Cancer Therapeutics, vol. 1, no. 8, pp. 639–649, 2002. View at Google Scholar · View at Scopus